JP2020172472A
|
|
Method for producing heterocyclic compound
|
JP2020152649A
|
|
Method for producing heterocyclic compound
|
JP2018145182A
|
|
Pharmaceutical composition
|
JP2018145181A
|
|
Vitamin b1-containing tablet
|
JP2019121020A
|
|
Method and system for temporarily predicting market infiltration of generic medicine
|
JP2018104097A
|
|
Secondary packaging body
|
JP2019085355A
|
|
Pharmaceutical composition
|
JP2021008407A
|
|
Heterocyclic compound
|
JP2018002716A
|
|
Solid formulation
|
JP2018090562A
|
|
Cyclic dinucleotide
|
JP2018092575A
|
|
Program, device, and method for predicting biological activity of chemical compound
|
JP2020097527A
|
|
Heterocyclic compound
|
JP2020097526A
|
|
Heterocyclic compound
|
JP2019196308A
|
|
Heterocyclic amide compound
|
JP2019196309A
|
|
Heterocyclic compound
|
JP2019196307A
|
|
Heterocyclic amide compound
|
JP2018035109A
|
|
Pharmaceutical composition
|
JP2017222626A
|
|
Heterocyclic compound
|
JP2017095372A
|
|
Biotin-containing liquid formulation
|
JP2015193617A
|
|
Vitamin c-containing liquid drug
|